|
|
|
|
|
by aroch
3884 days ago
|
|
I think the spirit of this to allow for drastically modified yeast that produce, say, anti-cancer drug X to be patented. To make the biological equivalent of an industrial methods patent. Otherwise you wouldn't be able to protect your IP even though significant effort has gone into creating a chimeric yeast, because its just a collection of natural products (natural product's are currently not patentable). Still, seems a little odd / slippery slope-y to me. On the one hand, I understand and, to some extent, agree with the need to protect / profit off what you've developed. On the otherhand, USPTO is pretty bad at biological patent screening and I can see a huge landrush to patent bacteria for no good reason. (Full disclosure, I am in the process of patenting a modified natural product made by a bacteria) |
|
It just seems like the wrong mechanism. Isn't the goal of restricting copying of your engineered organism better suited to the copyright system, rather than the patent system? Patents are for processes, right? But an organism is a thing, not a process. Isn't making an illegal copy of that thing a copyright violation?